相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer
Romualdo Barroso-Sousa et al.
CLINICAL CANCER RESEARCH (2020)
Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis
Xucheng Hou et al.
NATURE NANOTECHNOLOGY (2020)
An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors
Katharina Reinhard et al.
SCIENCE (2020)
Molecular mechanisms and cellular functions of cGAS-STING signalling
Karl-Peter Hopfner et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Regulation of the innate immune system by autophagy: monocytes, macrophages, dendritic cells and antigen presentation
Nina Germic et al.
CELL DEATH AND DIFFERENTIATION (2019)
Targeting PI3K in cancer: mechanisms and advances in clinical trials
Jing Yang et al.
MOLECULAR CANCER (2019)
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
Piotr S. Kowalski et al.
MOLECULAR THERAPY (2019)
Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System
Colette Moses et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Cancer nanomedicine for combination cancer immunotherapy
Jutaek Nam et al.
NATURE REVIEWS MATERIALS (2019)
Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy
Yan-ping Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation
Lei Miao et al.
NATURE BIOTECHNOLOGY (2019)
mRNA as novel technology for passive immunotherapy
Thomas Schlake et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
Qian Chen et al.
NATURE NANOTECHNOLOGY (2019)
Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition
Na Kong et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Recent advances in nanomaterial-based synergistic combination cancer immunotherapy
Wei Sang et al.
CHEMICAL SOCIETY REVIEWS (2019)
Mechanisms of resistance to immune checkpoint inhibitors
Russell W. Jenkins et al.
BRITISH JOURNAL OF CANCER (2018)
Tumour YAP1 and PTEN expression correlates with tumour-associated myeloid suppressor cell expansion and reduced survival in colorectal cancer
Rong Yang et al.
IMMUNOLOGY (2018)
Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer
Lina Liu et al.
MOLECULAR THERAPY (2018)
CK1α suppresses lung tumour growth by stabilizing PTEN and inducing autophagy
Junchao Cai et al.
NATURE CELL BIOLOGY (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
Rui Kuai et al.
SCIENCE ADVANCES (2018)
Biomedical applications of mRNA nanomedicine
Qingqing Xiong et al.
NANO RESEARCH (2018)
Myeloid-derived suppressor cells inhibit T cell activation through nitrating LCK in mouse cancers
Shan Feng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA
Mohammad Ariful Islam et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Future prospects of immune checkpoint blockade in cancer: from response prediction to overcoming resistance
Young-Jun Park et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Non-Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co-Delivery of Cas9 mRNA and sgRNA
Jason B. Miller et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
Suzanne George et al.
IMMUNITY (2017)
Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer
Tomasz M. Beer et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients
Hojabr Kakavand et al.
MODERN PATHOLOGY (2017)
Systemic delivery of factor IX messenger RNA for protein replacement therapy
Suvasini Ramaswamy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
Whijae Roh et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers
H. F. Moffett et al.
NATURE COMMUNICATIONS (2017)
Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses
Guangbao Yang et al.
NATURE COMMUNICATIONS (2017)
Engineering CRISPR-Cpf1 crRNAs and mRNAs to maximize genome editing efficiency
Bin Li et al.
NATURE BIOMEDICAL ENGINEERING (2017)
The functions of tumor suppressor PTEN in innate and adaptive immunity
Lang Chen et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Philip Gotwals et al.
NATURE REVIEWS CANCER (2017)
Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer
Gretchen K. Hubbard et al.
CANCER RESEARCH (2016)
Hyperthermic intraperitoneal chemotherapy leads to an anticancer immune response via exposure of cell surface heat shock protein 90
B. Zunino et al.
ONCOGENE (2016)
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
Weiyi Peng et al.
CANCER DISCOVERY (2016)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its Treatment
Zhenyu Zhong et al.
CELL (2016)
Chemotherapy and immunotherapy: mapping the road ahead
Alistair M. Cook et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
pH-Sensitive Polymeric Nanoparticles Modulate Autophagic Effect via Lysosome Impairment
Yao-Xin Lin et al.
SMALL (2016)
Self-Assembled Autophagy-Inducing Polymeric Nanoparticles for Breast Cancer Interference In-Vivo
Yi Wang et al.
ADVANCED MATERIALS (2015)
Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy
Andrew B. Sharabi et al.
LANCET ONCOLOGY (2015)
The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment
Madhav D. Sharma et al.
SCIENCE ADVANCES (2015)
PTEN: multiple functions in human malignant tumors
Michele Milella et al.
FRONTIERS IN ONCOLOGY (2015)
Autophagy: An adaptive metabolic response to stress shaping the antitumor immunity
Elodie Viry et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Autophagy-dependent ATP release from dying cells via lysosomal exocytosis
Yidan Wang et al.
AUTOPHAGY (2013)
Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug
Xiaoyang Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Mickael Michaud et al.
SCIENCE (2011)
Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival
Timothy W. Hand et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Control of autophagy by oncogenes and tumor suppressor genes
M. C. Maiuri et al.
CELL DEATH AND DIFFERENTIATION (2009)
The anticancer immune response: indispensable for therapeutic success?
Laurence Zitvogel et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Nanoparticles as a novel class of autophagy activators
Olga Zabirnyk et al.
AUTOPHAGY (2007)
Autophagy as a cell death and tumor suppressor mechanism
D Gozuacik et al.
ONCOGENE (2004)
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Y Nagata et al.
CANCER CELL (2004)
The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway
S Arico et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
